Topic Intelligence: ntra

gurufocus.com • 7h ago

Natera (NTRA) Gains Insight into Colorectal Cancer Treatment Outcomes

thelincolnianonline.com • 1d ago

Natera, Inc. $NTRA Shares Acquired by Fjarde AP Fonden Fourth Swedish National Pension Fund

Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 36.9% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 43,550 shares...

thelincolnianonline.com • 2d ago

Pictet Asset Management Holding SA Sells 1,956 Shares of Natera, Inc. $NTRA

Pictet Asset Management Holding SA cut its holdings in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 3.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund ...

simplywall.st • 2d ago

3 Healthcare Stocks Built For Higher Rates And Steady Demand

With jobs data softening, inflation holding at 4.2% and the Federal Reserve sticking to higher rates for longer, investors are paying closer attention to sectors that may offer some relative stability. Healthcare stocks sit squarely in that conversat...

simplywall.st • 3d ago

Natera (NTRA) Lands New Trial Partnerships, Is The Upside Already Priced In?

Natera (NTRA) has drawn fresh investor attention after a series of partnerships and approvals, including new Phase 3 trial collaborations and regulatory clearance for its Signatera test in Japan for colorectal cancer. See our latest analysis for Nate...

simplywall.st • 4d ago

Why Natera (NTRA) Is Up 6.3% After New Signatera Cancer Trial And Japan Launch Milestones

Natera, Inc. recently announced a series of collaborations and product advances, including integrating its Signatera MRD test into Aveta Biomics’ global Phase 3 head and neck cancer trial, expanding Prospera’s role in kidney transplant ...

zacks.com • 5d ago

NTRA & Aveta Partner to Advance MRD-Guided Trial in Head & Neck Cancer

finance.yahoo.com • 5d ago

NTRA & Aveta Partner to Advance MRD-Guided Trial in Head & Neck Cancer

Natera's Aveta partnership brings Signatera into a global Phase 3 head and neck cancer trial to assess MRD and treatment response.

simplywall.st • 6d ago

3 Stocks Estimated To Be Trading At A Discount Of Up To 48.9%

Over the last 7 days, the United States market has remained flat, yet it has seen a 20% increase over the past year with earnings projected to grow by 19% annually in the coming years. In this context, identifying stocks that are potentially underval...